Virtu Financial’s Takeda Pharmaceutical TAK Stock Holding History

Virtu Financial’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,164	Closed	-$191K	–	1886
2023 Q2	$191K	Buy	+12,164	New	+$199K	0.01%	836
2022 Q4	–	Sell	-10,719	Closed	-$139K	–	2115
2022 Q3	$139K	Buy	+10,719	New	+$149K	0.01%	996
2022 Q2	–	Sell	-10,105	Closed	-$145K	–	2061
2022 Q1	$145K	Sell	10,105 -1,030	-9%	-$15.1K	0.01%	881
2021 Q4	$152K	Sell	11,135 -21,722	-66%	-$305K	0.02%	945
2021 Q3	$538K	Buy	32,857 +13,306	+68%	+$223K	0.05%	434
2021 Q2	$329K	Buy	19,551 +2,042	+12%	+$34.8K	0.03%	673
2021 Q1	$320K	Buy	+17,509	New	+$315K	0.02%	778
2019 Q4	–	Sell	-11,527	Closed	-$198K	–	1832
2019 Q3	$198K	Sell	11,527 -524	-4%	-$9.06K	0.02%	979
2019 Q2	$213K	Buy	+12,051	New	+$219K	0.01%	1001

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial's TAK Position: Q3 2023 in Review

Virtu Financial sold out of Takeda Pharmaceutical (TAK) in Q3 2023, closing a stake of 12,164 shares — an estimated $191K sold.

Virtu Financial first reported a position in TAK in Q2 2019 and held it in 9 quarters. The position peaked at $538K in Q3 2021. 313 funds tracked by Wall St. Rank hold TAK as of Q3 2023.

Virtu Financial reported no remaining Takeda Pharmaceutical position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 12,164 Takeda Pharmaceutical shares in Q3 2023, an estimated $191K.
Virtu Financial first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 9 quarters.
Virtu Financial's Takeda Pharmaceutical position peaked at $538K in Q3 2021.
313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.